Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Telia Company completes change program and implements decentralized country-led approach

Telia Company has completed its change program announced on September 4  and lowered the company’s cost base through a reduction of 3,000 positions, while decentralizing its organization as part of a new country-led operating model. This will support commercial excellence and in turn deliver profitable growth. As previously communicated, the changes will provide annual savings of at least SEK 2.6 billion and reinforce Telia’s

SSC and Ovzon further broadens and deepens collaboration

Swedish Space Corporation (SSC) and Ovzon have signed a teaming agreement to broaden, deepen and strengthen the already successfully developed partnership with the aim to develop unique sovereign space and satellite capabilities. Sovereign space capabilities allow a country to operate space systems independently, when and where they want. They are important for national security, economic competitiveness and resilience in today’s rapidly evolving geopolitical landscape. Ovzon, with its disruptive Ovzon 3 satellite, and SSC, with its extensive space service portfolio, are uniquely

Eevia is subject to a possible reverse takeover

Eevia Health Plc (”Eevia" or "The Company") received a proposal for a reverse takeover (RTO) from Stemtech Corporation[1] (“Stemtech”), a US company, on November 10. The proposal suggests that Eevia buy the US company's assets (“Stemtech Assets”) and issue new shares to the US company, providing that Stemtech will own c. 85% of the new outstanding shares after such a transaction. Stemtech recently announced its pending merger with Seacret Direct LLC, DBA VIÁGO ("Viago"), and the Stemtech Assets include the assets of Viago and Stemtech. Stemtech's valuation would be approximately 40 MUSD,

Terveystalo updates its medium-term financial targets

Terveystalo Oyj, Stock Exchange Release, 2 December 2024 at 08:00 (EET) Terveystalo’s Board of Directors has approved the company’s updated financial targets and dividend policy for the medium term. All targets have been updated to reflect the company's improved performance and focus on value creation. Terveystalo’s updated financial targets and dividend policy are as follows: Profitable growth: · EPS to grow on average by 10% p.a. · We expect faster earnings per share growth in 2025, as fewer items affecting comparability are expected Moderate leverage ratio: · Net

Divestment of private and life insurance operations in Finland finalised

On 31 May 2023 Handelsbanken entered into an agreement to divest the private and life insurance operations in Finland. The divestments have now been completed and the operations have been transferred to S-bank Abp and Fenni Life Insurance, respectively. The transactions included lending volumes of approximately EUR 2.5 billion (SEK 28 billion), corresponding to a risk weighted exposure amount of approximately EUR 1.0 billion (SEK 11 billion), as well as deposit volumes of approximately EUR 0.9 billion (SEK 10 billion) and total assets under management of approximately EUR 2.0 billion (

The last day of trading in warrants of series TO2 is on the 3[rd] of December 2024

The 3[rd] of December 2024 is the last day of trading in warrants of series TO2, which were issued in connection with Curasight A/S ("Curasight" or the "Company") preferential rights issue and directed issue of units in September 2024. The exercise period runs until the 5[th] of December 2024.In connection with the Company's preferential rights issue and directed issue of units, carried out in September 2024, 3,683,814 warrants of series TO2 were issued. Holders of TO2 have the right to subscribe for one (1) new share in Curasight at a price of DKK 11.50 per share during the exercise period,

Business Sweden leads a large business delegation to South Korea and Japan from 3–6 December alongside Prime Minister Ulf Kristersson.

As part of the Government’s Asia initiative, Business Sweden is leading a large business delegation to South Korea and Japan to strengthen and expand trade relations with these key partners.“We are taking important steps to further deepen trade relations with Japan and South Korea. A significant business delegation will accompany the Prime Minister and ministers on this visit. Asia continues to grow in importance, with high growth expected to persist. Countries like South Korea and Japan are vital partners with whom we aim to foster closer cooperation,” says Jan Larsson, CEO of Business

Zwipe AS – Commencement of Exercise Period for Warrants issued in the 2023 Rights Issue

THIS PRESS RELEASE MAY NOT BE MADE PUBLIC, PUBLISHED OR DISTRIBUTED, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, BELARUS, HONG KONG, JAPAN, CANADA, NEW ZEALAND, RUSSIA, SWITZERLAND, SINGAPORE, SOUTH AFRICA, THE UNITED STATES OR ANY OTHER JURISDICTION IN WHICH SUCH ACTIONS, WHOLLY OR IN PART, WOULD BE UNLAWFUL. THIS PRESS RELEASE DOES NOT CONSTITUTE AN OFFER TO BUY SECURITIES IN ZWIPE AS. SEE ALSO THE SECTION "IMPORTANT INFORMATION" BELOW IN THIS DOCUMENT.Reference is made to the stock exchange announcements published by Zwipe AS (the "Company") on 14 December 2023, regarding the final

Share Savings Plan Transaction

As a part of the share savings plan for employees in 2024, the following primary insiders have purchased Bakkafrost shares: · Regin Jacobsen, CEO, purchased 49 shares. After the transaction, he holds directly and indirectly 4,641,950 shares. · Høgni Dahl Jakobsen, CFO, purchased 35 shares. After the transaction, he holds directly and indirectly 78,198 shares. · Odd Eliasen, Managing Director, purchased 35 shares. After the transaction, he holds 187,904 shares. · Annika Frederiksberg, Board Member, purchased 13 shares. After the transaction, she holds directly and indirectly 17,

CS MEDICA: Q4 Interim report, July – September 2024

CS MEDICA today released its financial results for the fourth quarter of 2024, demonstrating revenue growth and enhanced operational efficiency despite challenging market conditions and financial constraints. A last-minute postponement of a merger and acquisition initiative impacted the annual results, leading to a 46% deviation from projected revenue.CS MEDICA A/S (CSMED), a Danish MedTech company specializing in CBD-infused medical devices, concluded the fiscal year 2023/2024 with a transformative fourth quarter, marked by progress and positive revenue growth. However, the quarter was

Notice convening the Extraordinary General Meeting of Avida Finans AB (publ), reg. no. 556230-9004 (the "Company")

Day and time: Monday, 30 December 2024, at 10:00 CET. Place: Avida Finans AB (publ)'s office, Magnus Ladulåsgatan 65, 118 28 Stockholm, Sweden.NOTIFICATION ETC. Shareholders who wish to participate in the Extraordinary General Meeting need to i) be listed as a shareholder in the share register maintained by Euroclear Sweden AB no later than on the record date which is Tuesday 17 December 2024, and ii) give notice of participation to the Company no later than on Monday 23 December 2024 in writing to: Avida Finans AB (publ) Box 38101, 100 64 Stockholm, Sweden (mark the envelope "

Notice convening the Extraordinary General Meeting of Avida Finans AB (publ), reg. no. 556230-9004 (the "Company")

Day and time: Monday, 16 December 2024, at 10:00 CET. Place: Avida Finans AB (publ)'s office, Magnus Ladulåsgatan 65, 118 28 Stockholm, Sweden.NOTIFICATION ETC. Shareholders who wish to participate in the Extraordinary General Meeting need to i) be listed as a shareholder in the share register maintained by Euroclear Sweden AB no later than on the record date which is Friday, 6 December 2024, and ii) give notice of participation to the Company no later than on Tuesday, 10 December 2024 in writing to: Avida Finans AB (publ) Box 38101, 100 64 Stockholm, Sweden (mark the envelope "

Lundin Mining Announces Updated Share Capital and Voting Rights

VANCOUVER, BC, November 29, 2024 /CNW/ - (TSX: LUN; Nasdaq Stockholm: LUMI) Lundin Mining Corporation (“Lundin Mining” or the “Company”) reports the following updated share capital and voting rights, in accordance with the Swedish Financial Instruments Trading Act: The number of issued and outstanding shares of the Company has increased by 28,519 to 776,905,492 common shares with voting rights as of November 29, 2024. The increase in the number of issued and outstanding shares from November 1, 2024 to date is a result of the exercise of employee stock options or the vesting of employee

Lundin Gold Share Capital and Voting Rights Update

VANCOUVER, BC, Nov. 29, 2024 /CNW/ - Lundin Gold Inc. (TSX: LUG; Nasdaq Stockholm: LUG; OTCQX: LUGDF) ("Lundin Gold" or the "Company") reports the following in accordance with the Swedish Financial Instruments Trading Act. As a result of the exercise of stock options under Lundin Gold's equity compensation plan and the exercise of previously granted anti-dilution rights of the Company's largest shareholder during the month of November, the Company now has 240,194,898 common shares issued and outstanding with voting rights as at November 29, 2024.  This figure may be used by

Noble Corporation plc announces changes to its share capital including share repurchases for the month of November 2024

SUGAR LAND, TEXAS, Nov. 29, 2024 /PRNewswire/ - Noble Corporation plc ("Noble") (NYSE: NE, CSE: NOBLE) today announces changes to its share capital. During the month of November, Noble has repurchased approximately USD 36.6 million of A ordinary shares under its previously announced share repurchase plan at a weighted average price of approximately USD 33.85 per A ordinary share. During the period since October 31, 2024, 12,536 new A ordinary shares each with a nominal value of USD 0.00001 have been issued. 6,992 new A ordinary shares have been issued to certain holders of warrants as

Nordea Bank Abp: Repurchase of own shares on 29.11.2024

Nordea Bank AbpStock exchange release – Changes in company’s own shares29.11.2024 at 22.30 EET Nordea Bank Abp (LEI: 529900ODI3047E2LIV03) has on 29.11.2024 completed repurchases of own shares (ISIN: FI4000297767) as follows: +----------+-------+-------------------+-------------------+| Trading |Number | Weighted average |Total cost, EUR* **||venue (MIC| of |price / share, EUR*| || Code) |shares | ** | |+----------+-------+-------------------+-------------------+|XHEL |142,617|10.69 |1,524,689.

Mandatory Notification of Trade

Hamilton, Bermuda, November 29, 2024 - Paratus Energy Services Ltd. (ticker "PLSV") (the "Company") has been notified of a trade completed by a fund managed by Lodbrok Capital LLP, a close associate to board member Joachim Bale. For further information, please see the attached mandatory notification of trade. This information is subject to the disclosure requirements in articles 19 of the Regulation EU 596/2014 (the EU Market Abuse Regulation) and section 5-12 of the Norwegian Securities Trading Act.

Integrum AB: Invitation to the Second Quarter 2024/25 Results Presentation

Mölndal, Sweden – November 29, 2024 — Integrum (publ) (Nasdaq First North Growth Market: INTEG B) will host a webcast presentation of its second quarter 2024/25 results on December 4, 2024 at 14:00 CEST.Integrum’s CEO Scott Flora will present the report together with CFO Jörgen Svanström in a webcast. The presentation will be held in English. Time: Wednesday, December 4, 2024 at 14:00 CEST. Location: Webcast (see link below). The report will be available at https://integrum.se/investor-relations/financial-reports-calendar/ The webcast and presentation material will be accessible

Update to Force BidCo A/S Q3 2024 Report

A processing error means that Force BidCo A/S has provided the wrong figure for the leverage ratio in the Q3 2024 report in the highlights overview on page 2 and the Net Debt figures on page 7.The correct leverage ratio should be 3.1x. The error is isolated to the Q3 2024 reporting and does not affect any other figures in this report. The corrected Q3 2024 financial statement has been share as part of this press release and is also corrected at www.FairWind.com

Number of shares and votes in BioArctic AB (publ) as of November 29, 2024

Stockholm, November 29, 2024 – BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) announced today that the company during November issued 14,500 Class B shares for delivery of shares to participants in the 2019/2028 stock option program resolved at the Annual General Meeting on May 9, 2019. The shares were issued through an exercise of 14,500 options of series 2019/2028.As of November 29, 2024, the last trading day of the month, the total number of shares in BioArctic AB amounts to 88,389,035 shares, of which 73,989,039 listed Class B shares and 14,399,996 unlisted Class A shares. The A share

Sale of 20,143,293 existing shares in Pierce Group AB completed

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES, AUSTRALIA, CANADA, NEW ZEALAND, HONG KONG, JAPAN OR ANY OTHER JURISDICTION WHERE SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. OTHER RESTRICTIONS ARE APPLICABLE. PLEASE SEE IMPORTANT INFORMATION AT THE END OF THE PRESS RELEASE.Procuritas Capital Investors V GP Limited acting as General Partner to Procuritas Capital Investors V, LP and PCI V Co-Investment AB (together “Procuritas” or the “Selling Shareholder”) has sold 20,143,293 existing shares in Pierce Group AB (“

There are no items matching the current filter
There are no more items matching the current filter
Back to top